HomePAR • ASX
add
Paradigm Biopharmaceuticals Ltd
Previous close
$0.25
Day range
$0.25 - $0.26
Year range
$0.24 - $0.48
Market cap
114.21M AUD
Avg Volume
1.01M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 12.58K | 50.60% |
Operating expense | 10.92M | 244.32% |
Net income | -11.62M | -292.37% |
Net profit margin | -92.42K | -160.54% |
Earnings per share | — | — |
EBITDA | -10.88M | -246.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.74M | -40.53% |
Total assets | 23.15M | -34.52% |
Total liabilities | 17.16M | 1,217.97% |
Total equity | 6.00M | — |
Shares outstanding | 428.52M | — |
Price to book | 25.00 | — |
Return on assets | -117.85% | — |
Return on capital | -177.46% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -11.62M | -292.37% |
Cash from operations | -9.82M | -139.05% |
Cash from investing | -283.60K | -1,327.71% |
Cash from financing | 9.15M | 21.02% |
Net change in cash | -1.08M | -130.97% |
Free cash flow | -7.34M | -283.05% |
About
Founded
2014
Website
